Current Opinion in Nephrology and Hypertension

Article	Citations
Dual organ transplantation: Pancreas and Liver in the kidney axis	50
Emerging strategies to reduce kidney function decline and improve cardiovascular outcomes	36
Editorial introductions	34
Does cooled dialysate still have a role in reducing intradialytic stress? Implications of the MyTEMP trial	31
The impact of conflicts on patients with chronic kidney disease	28
Tackling the intersectoral challenges in kidney diseases and transplantation: shared decision and realistic care for advanced diagnostic and therapeutic modalities for kidney diseases and transplantat	28
Microvascular inflammation in the kidney transplant, beyond acute antibody-mediated rejection	24
Population Health Strategies for Health Equity in Chronic Kidney Disease Management: Retraction	21
Evolution in the targets for blood pressure treatment	21
Effect of the allelic background on the phenotype of primary hyperoxaluria type I	19
Interferon gamma in the pathogenesis of hypertension − recent insights	18
Editorial introduction	18
Maximizing opportunities for kidney transplantation in older adults	18
Barriers to home dialysis and kidney transplantation for socially disadvantaged individuals	18
Safety of SGLT2i with regard to bone and mineral metabolism in patients with CKD	17
Prediction models for earlier stages of chronic kidney disease	17
Renal denervation for the treatment of hypertension and kidney disease	16
Has the time come for age-adapted glomerular filtration rate criteria to define chronic kidney disease: how soon is now?	15
Modern indications for referral for kidney and pancreas transplantation	15
International equity in access to home dialysis	15
Dialysis initiation for patients with decompensated cirrhosis when liver transplant is unlikely	14
Recent advances in peritoneal dialysis catheter placement: the association between method of insertion, operator, and prior abdominal surgery and outcomes	14
Editorial: The evolution of my personal conflict of interest: I am part of an ‘ineligible company’	13
Plant-based diets for kidney disease prevention and treatment	13
Updates in tolerance: future directions to improve kidney allograft survival	13

Bringing the end-stage kidney disease life plan home	13
Skeletal parathyroid hormone hyporesponsiveness: a neglected, but clinically relevant reality in chronic kidney disease	13
Calcium phosphate microcrystallopathy as a paradigm of chronic kidney disease progression	12
Calcium-binding protein 39 in with-no-lysine kinase signaling and the modulation of renal tubular transport	12
Built environment and chronic kidney disease: current state and future directions	12
Hypertension guidelines need to be patient oriented	12
The race coefficient in glomerular filtration rate-estimating equations and its removal	12
Synergistic susceptibility to environmental lead toxicity in chronic kidney disease	12
Staying home when peritoneal dialysis ends: the integrated home dialysis approach	12
Sodium phosphate cotransporter 2a inhibitors: potential therapeutic uses	12
Bringing medical education “home”: the university health network and St. Michael's hospital home dialysis fellowship	11
Stopping renin–angiotensin–aldosterone system inhibitors in kidney disease	11
A basic solution for a complex problem: does treatment of metabolic acidosis slow CKD progression?	11
Editorial: One size does not fit all: moving toward individualized therapy	11
Complement detection in kidney biopsies – utility and challenges	11
Understanding renal phosphate handling: unfinished business	11
Which patients with CKD will benefit from genomic sequencing? Synthesizing progress to illuminate the future	11
Editorial introductions	10
A guide for program development of environmentally sustainable kidney care	10
Renal effects of cullin 3 mutations causing familial hyperkalemic hypertension	10
Dietary protein intake and plant-dominant diets to mitigate risk of allograft dysfunction progression in kidney transplant recipients	10
New advances in the diagnosis and pathologic spectrum of monoclonal gammopathy of renal significance	10
Recent insights into the role of dietary phosphorus in the development and progression of chronic kidney disease–mineral and bone disorder	10
Combination therapy with kidney protective therapies: optimizing the benefits?	10
Lipocalin-2: a novel link between the injured kidney and the bone	10
Editorial: Advancements in the management of kidney disease and electrolyte derangements	9
When the earth shakes unexpectedly: impact on nephrology services and patients	9
Paracellular transport along the nephron in physiology and pathophysiology	9
Editorial introductions	9
Cancer drugs and acute kidney injury: new therapies and new challenges	9
A current update of the development of Chimeric Antigen Receptor T-cell therapy and kidney disease	9
Climate change and kidney stones	9
The current therapeutic approach for anaemia after kidney transplant	8
Novel therapeutic approaches for phosphate regulation	8
Impact of intensive blood pressure control on kidney outcomes	8
Automation and innovation in home hemodialysis machines	8
Mitochondrial bioenergetics: coupling of transport to tubular mitochondrial metabolism	8
Recent updates in kidney risk prediction modeling: novel approaches and earlier outcomes	8
Update on antineutrophil cytoplasmic antibody vasculitis: Erratum	8
HIV-associated kidney disease: the changing spectrum and treatment priorities	8
Editorial introductions	8
Editorial: Innovations in multimodal and integrated approaches in kidney care and renal transplantation	8
Glucagon-like peptide-1 receptor agonists to improve cardiorenal outcomes: data from FLOW and beyond	8
New and old approaches to nutritional management of acute and chronic glomerulonephritis	8
Deep learning applications for kidney histology analysis	8
Implications of the cystatin C/creatinine discordance	8
Recent advances in treatment options for kidney disease	7
C3 glomerulopathy: advancements in diagnostics and therapeutics	7
Prospects for gene therapy in polycystic kidney disease	7
Sex differences in renal electrolyte transport	7

Editorial introduction	7
Editorial introductions	7
New insights into renal calcium-sensing receptor activation	7
New regulators of parathyroid hormone secretion	7
Evolving thresholds for the diagnosis of acute T cell mediated rejection	7
Renal osteodystrophy: something old, something new, something needed	7
Editorial introductions	7
Rare genetic disorders that impair parathyroid hormone synthesis, secretion, or bioactivity provide insights into the diagnostic utility of different parathyroid hormone assays	7
Proximal tubule responses to injury: interrogation by single-cell transcriptomics	6
Multimodal approaches for inequality in kidney care: turning social determinants of health into opportunities	6
An update on the epidemiology of chronic kidney disease of uncertain etiology	6
Screening for chronic kidney disease: change of perspective and novel developments	6
Staff-assisted peritoneal dialysis in the United States: from evidence to national adoption	6
Adverse effects during treatment with renin–angiotensin–aldosterone system inhibitors; should we stay or should we stop?	6
The changing trajectory of diabetic kidney disease	6
The genetics of cystinuria – an update and critical reevaluation	6
Enhancing accuracy and adherence in blood pressure monitoring in living kidney donation: implementing technologies to overcome challenges	6
Building kidney organoids from pluripotent stem cells	6
Vaccination in kidney disease: what did we learn from COVID-19 pandemic	6
Therapies in autosomal dominant polycystic kidney disease: beyond tolvaptan	6
Novel approaches in antihypertensive pharmacotherapeutics	6
Peritoneal dialysis and heart failure	6
Frailty, multimorbidity and sarcopaenia in haemodialysis patients	6
Early changes in kidney function in young adults: what is the significance?	6
Evolving indications and management patterns in heart – kidney transplantation	6
Prevention of postoperative acute kidney injury: insights from recent clinical trials	6
New therapeutic perspectives for vascular and valvular calcifications in chronic kidney disease	6
Systemic versus local regulation of vitamin D	6
Renal denervation: recent developments in clinical and preclinical research	6
Targeting inflammation in hypertension	6
Chronic kidney disease and sex dimorphism	6
New guidelines and therapeutic updates for the management of lupus nephritis	6
Exercise as a therapeutic intervention in chronic kidney disease: are we nearly there yet?	6
Population health strategies for health equity in chronic kidney disease management	5
Effects of aging on chronic kidney disease mineral and bone disorder	5
Hypophosphatemia in kidney stone formers	5
The role of calprotectin in vascular calcification	5
WNK1 in the kidney	5
Mendelian randomization and the association of fibroblast growth factor-23 with heart failure with preserved ejection fraction	5
Diagnosing acute tubulointerstitial nephritis: novel biomarkers address an important clinical challenge	5
Fibroblast growth factor 23 at the crossroads of mineral metabolism and bone disease	5
An update on corticosteroid treatment for IgA nephropathy	5
Reimagining kidney value-based care: leveraging data science for dynamic, clinician-level risk prediction	5
Fibroblast growth factor 23 as a risk factor for incident diabetes	5
Methotrexate nephrotoxicity: a pragmatic approach	5
Fifty years of basic and clinical renal stone research: have we achieved major breakthroughs? A debate	5
Glomerular filtration rate and sexual dimorphism: lessons from animal and human studies	5
Editorial introductions	5
Novel agents for treating IgA nephropathy	5
Cystatin C should be routinely available for estimating kidney function	5
Electrolytes disturbances in cancer patients	5
Role of inwardly rectifying K+ channel 5.1 (Kir5.1) in the regulation of renal membrane transport	5
Insights into proliferative glomerulonephritis with monoclonal immunoglobulin deposits – is it really monoclonal or not?	5
Updated diagnostic and therapeutic management for membranous nephropathy	5
Fibroblast growth factor 23, klotho and heparin	4
Novel insights in the regulation of intercalated cell differentiation	4
Centering marginalized voices in advocacy for equitable policy change in kidney disease	4
Literature review: are NSAIDs harmful and is acetaminophen well tolerated?	4
Phosphate sensing in health and disease	4
Agents to treat osteoporosis in chronic kidney disease	4
The promise of artificial intelligence for kidney pathophysiology	4
Progress in the management of patients with diabetes and chronic kidney disease	4
Climate change and its influence in nephron mass	4
Tackling the epidemic of obesity and hypertension in children and young people	4
Editorial introductions	4
Updates on renal phosphate transport	4
Climate crisis and nephrology: a review of climate change's impact on nephrology and how to combat it	4
Editorial introductions	4
Medullary sponge kidney and chronic pain: is there a role for renal denervation	4
Editorial: Narrow the gap, build a bridge: an inspirational approach to chronic kidney disease–mineral and bone disorder	4
Postnatal renal tubule development: roles of tubular flow and flux	4
Management of antineutrophil cytoplasmic antibody-associated vasculitis: a changing tide	4
The times they are K+-changin’: bringing the potassium curriculum out of the 20th century	4
Editorial introductions	4
Indications for and results of renal autotransplantation	4
The role of osteopontin in chronic kidney disease-mineral bone disorder	4
Time-limited trials for acute dialysis decision-making for critically ill older patients: rationale, communication strategies, and future research	4
Home dialysis: there's no place like home	4
Chronic kidney disease with unknown cause across the global spectrum	3
Update on antineutrophil cytoplasmic antibody vasculitis	3

Editorial introductions	3
New pharmacological therapies for hypertension	3
Recent advances in the understanding of the peritoneal membrane	3
The obesity and lipid paradoxes in chronic kidney disease: mechanisms, interventions, and future directions	3
Novel pharmacological interventions for diabetic kidney disease	3
Challenges and advances in the management of antineutrophil cytoplasmic antibody vasculitis in 2025	3
Artificial intelligence in kidney disease and dialysis: from data mining to clinical impact	3
Living after acute kidney injury: understanding the physical and psychosocial consequences	3
Persistent hyperparathyroidism in long-term kidney transplantation: time to consider a less aggressive approach	3
Calciprotein particles: is it time for therapeutic intervention?	3
Justifying access to kidney care in low resource and humanitarian settings	3
SLC26A1 directs sulfate homeostasis in health and disease	3
Oh, My Gut! New insights on the role of the gastrointestinal tract and the gut microbiome in chronic kidney disease-mineral and bone disorder	3
Promises and limits of biopsy-based transcriptomics in kidney transplantation: a clinical utility perspective	3
Lysine and salt-sensitive hypertension	3
Heating up: climate change and the threat to human health	3
Challenges in standardizing preimplantation kidney biopsy assessments and the potential of AI-Driven solutions	3
Targeting aldosterone to improve cardiorenal outcomes: from nonsteroidal mineralocorticoid receptor antagonists to aldosterone synthase inhibitors	3
Use of water in dialysis and its impact on the environment	3
Diagnostic and therapeutic challenges in implementing hypertension management after kidney transplantation	3
Implications of climate change on acute kidney injury	3
Continuous glucose monitoring in patients with chronic kidney disease on dialysis and with kidney transplantation	3
APOL1 nephropathy – a population genetics success story	3
Do not forget about transplant patients during disasters	3
Kidney health and function with left ventricular assist devices	3
Revisiting the relationship between (Pro)Renin receptor and the intrarenal RAS: focus on the soluble receptor	3
Let's stop talking about ‘citrate toxicity’	3
Skin autofluorescence as tool for cardiovascular and diabetes risk prediction	3
Social and humanitarian issues in nephrology and hypertension	3
Community acquired and hospital acquired AKI - two diseases divided by a common definition	3
Applications of cardiac biomarkers in chronic kidney disease	3
Pruritus in chronic kidney disease	3
Mitochondrial DNA – novel mechanisms of kidney damage and potential biomarker	3
New insights into clinical spectrum of antineutrophil cytoplasmic autoantibody associated disease	3